Prostatic Neoplasms: Ling M

  Topic:  
Hints · Remembered Topics    
  Start Here  Overview  World Articles  Find Experts  Books & DVDs  Help 
 
Column View Map 2 Articles Retractions   Help
A digest of articles written 1999 and later, on the topic "Prostatic Neoplasms," originating from Planet Earth —» Ling M.  Display:  All Citations ·  All Abstracts
1 Minor Hemorrhagic ascites: an unusual manifestation of prostate carcinoma. 2001

Tsai JY, Ling M, Chang VT, Hwang SS, Kasimis BS. · No affiliation provided · Am J Med. · Pubmed #11545100 No free full text.

This publication has no abstract.

2 Retraction Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines. free! 2003

Xu K, Wang X, Ling M, Wong Y. · Department of Urology, People's Hospital, Peking University, Beijing 100044, China. · Chin Med J (Engl). · Pubmed #14642133 links to  free full text

Abstract: OBJECTIVE: To study the effects of an alpha(1)-adrenoceptor antagonist, terazosin on the androgen-independent prostate cancer cell lines PC-3 and DU145. METHODS: Two androgen independent cell lines, PC-3 and DU145, were used to determine cell viability, colony-forming ability, as well as cell cycle distribution, after exposure to terazosin. Western blot analysis was used to determine the expression of p21WAF1 and p27KIP1. RESULTS: This study shows that terazosin inhibits not only prostate cancer cell growth but also its colony forming ability, both of which are main targets of clinical treatment. In addition, terazosin is shown to inhibit cell growth through G1 phase cell cycle arrest and the up-regulation of p27(KIP1). CONCLUSION: This study provides evidence that the alpha(1)-adrenoceptor antagonist terazosin may have therapeutic potential in the treatment of advanced hormone refractory prostate cancer.